SILENCE THERAPEUTICS PLC (SLN)
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
ALPHA TAU MEDICAL LTD. (DRTS)
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
IN8BIO, INC. (INAB)
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ERASCA, INC. (ERAS)
Erasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRIDGEBIO PHARMA, INC. (BBIO)
BridgeBio Reports Second Quarter 2026 Financial Results and Corporate Updates
SEPTERNA, INC. (SEPN)
Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results
C4 THERAPEUTICS, INC. (CCCC)
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AIRJOULE TECHNOLOGIES CORP. (AIRJ)
AirJoule Technologies Schedules Release of Second Quarter 2026 Results and Conference Call
OLEMA PHARMACEUTICALS, INC. (OLMA)
Olema Oncology Reports Second Quarter 2026 Financial and Operating Results
NVIDIA CORP (NVDA)
NVIDIA Partners With Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR to Establish AI Compute Infrastructure Financing Platforms to Mobilize Over $500 Billion of Third-Party Capital